Get started
Author

Maartje C.A. Wouters

Observed names: M. C. A. Wouters, M. Wouters, M.C.A. Wouters, MCA Wouters, Maartje C A Wouters, Maartje C. A. Wouters, Maartje C. Wouters, Maartje CA Wouters, Maartje Ca Wouters, Maartje Cornelia Ardina Wouters, Maartje Wouters, Wouters, M. C. A.
Observed institutions: BC Cancer Agency, University Medical Center Groningen, Radboud University Nijmegen, University of Groningen, Radboud University Medical Center, AgelessRx (United States)
ORCID: 0000-0001-5829-6973
Observed ORCID: 0000-0001-5829-6973
OpenAlex ID: A5063693344
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
2018 · Maartje C.A. Wouters, Brad H. Nelson · Clinical Cancer Research · 496
A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
2019 · Hagma H. Workel, Joyce M. Lubbers, et al. · Cancer Immunology Research · 263
PDF
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
2015 · E.M. Dijkgraaf, S.J.A.M. Santegoets, et al. · Annals of Oncology · 197
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
2012 · Eleni van Schooneveld, Maartje CA Wouters, et al. · Breast Cancer Research · 191
PDF
CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
2016 · Hagma H. Workel, Fenne L. Komdeur, et al. · European Journal of Cancer · 141
PDF
Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
2021 · Céline M. Laumont, Maartje C.A. Wouters, et al. · Clinical Cancer Research · 103
PDF
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2017 · Dale W. Garsed, Kathryn Alsop, et al. · Clinical Cancer Research · 92
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
2015 · Maartje C.A. Wouters, Fenne L. Komdeur, et al. · Clinical Cancer Research · 81
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
2016 · Fenne L. Komdeur, Maartje C.A. Wouters, et al. · Oncotarget · 69
PDF
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers
2020 · Julian Smazynski, Phineas T. Hamilton, et al. · Gynecologic Oncology · 36
PDF
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome
2020 · Kim L. Brunekreeft, Sterre T. Paijens, et al. · OncoImmunology · 35
CD20+T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer
2015 · Marco de Bruyn, Valerie R Wiersma, et al. · OncoImmunology · 34
PDF
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer
2014 · MCA Wouters, EM Dijkgraaf, et al. · OncoImmunology · 32
PDF
Cancer Immunotherapy Principles and Practice
2017 · Lisa H. Butterfield, Howard L. Kaufman, et al. · Springer Publishing Company eBooks · 30
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity
2015 · Valerie R Wiersma, Marco de Bruyn, et al. · mAbs · 28
PDF
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer
2020 · Allyson C. Banville, Maartje C.A. Wouters, et al. · Gynecologic Oncology · 27
The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals
2025 · Girish Harinath, Virginia Lee, et al. · GeroScience · 10
PDF
The role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials
2024 · Girish Harinath, Sajad Zalzala, et al. · Ageing Research Reviews · 8
Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation
2016 · M. C. A. Wouters, F. L. Komdeur, et al. · OncoImmunology · 3
PDF
The bioavailability of compounded and generic rapamycin in normative aging individuals: A retrospective study and review with clinical implications
2024 · Girish Harinath, Virginia Lee, et al. · medRxiv · 1
PDF
Low-Dose Naltrexone as a Potential Healthspan-Enhancing Intervention in a Normative Aging Cohort: Changes in Quality of Life and Immune Health Metrics
2024 · Girish Harinath, Sajad Zalzala, et al. · 1
PDF
Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors
2019 · Dale W. Garsed, Ahwan Pandey, et al. · Cancer Research · 1
The Multifaceted Roles of B Cells and Plasma Cells in Antitumor Immunity
2018 · Maartje C. A. Wouters, Brad H. Nelson · Springer Publishing Company eBooks · 1
The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada
2017 · Maartje C. A. Wouters, Céline M. Laumont, et al. · Cancer Immunology Immunotherapy · 1
Data from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
2023 · Hagma H. Workel, Joyce M. Lubbers, et al.
Works count: 125
Citation count: 1,880
H-index: 16
I10-index: 17
Year
Topic
Type